ROTUNNO, GIADA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.792
EU - Europa 2.351
AS - Asia 528
AF - Africa 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.784
RU - Federazione Russa 845
PL - Polonia 471
IT - Italia 363
IE - Irlanda 214
CN - Cina 179
SE - Svezia 170
SG - Singapore 161
HK - Hong Kong 84
CH - Svizzera 70
DE - Germania 57
FI - Finlandia 50
JO - Giordania 38
GB - Regno Unito 36
IN - India 33
FR - Francia 25
ES - Italia 17
VN - Vietnam 14
CI - Costa d'Avorio 11
BE - Belgio 8
CA - Canada 8
NL - Olanda 7
TW - Taiwan 6
AT - Austria 5
UA - Ucraina 5
BG - Bulgaria 4
BR - Brasile 3
JP - Giappone 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
PK - Pakistan 2
RO - Romania 2
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
MY - Malesia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 6.690
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.067
Warsaw 466
Fairfield 414
Ashburn 249
Woodbridge 225
Chandler 222
Dublin 214
Seattle 201
Cambridge 158
Houston 154
Wilmington 147
Singapore 119
Ann Arbor 112
Florence 87
Altamura 82
Lawrence 80
Bern 70
Beijing 64
Princeton 60
Buffalo 46
Hong Kong 46
Boston 33
Bremen 30
San Diego 29
Shanghai 29
Moscow 25
Mumbai 25
New York 24
Helsinki 23
Medford 21
Los Angeles 19
Barcelona 15
Kent 15
Boardman 14
Dearborn 12
Dong Ket 12
Abidjan 11
Hillsboro 11
Rome 11
Norwalk 9
Brussels 8
Claymont 8
Hangzhou 7
Pune 7
Cagliari 6
Fiesole 6
Fuzhou 6
Hefei 6
Milan 6
Pian di Scò 6
London 5
Vienna 5
Andover 4
Blagoevgrad 4
Cantagallo 4
Jacksonville 4
Nanjing 4
Paris 4
Red Deer 4
Redwood City 4
Romainville 4
Yubileyny 4
Berlin 3
Brescia 3
Faenza 3
Falkenstein 3
Jinan 3
Kilburn 3
Munich 3
Nanchang 3
Pavia 3
Phoenix 3
Rochester 3
San Jose 3
Seoul 3
São Paulo 3
Abu Dhabi 2
Bologna 2
Burghausen 2
Cedar Knolls 2
Cipolletti 2
Costa Mesa 2
Falls Church 2
Gambettola 2
Guangzhou 2
Islamabad 2
Islington 2
Kunming 2
Lugo 2
Maranello 2
Modena 2
Newark 2
Nürnberg 2
Padova 2
Pisa 2
Poggio A Caiano 2
Reston 2
Rhinelander 2
Rimini 2
San Gavino Monreale 2
Totale 4.857
Salva come PNG Salva come JPEG
Nome #
Study of mutation complexity in Chronic Myeloproliferative Neoplasms: pathogenetic insights and translational relevance 291
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 274
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 214
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 214
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis 188
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group 181
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 167
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 163
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 157
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 152
Mutations and prognosis in primary myelofibrosis. 150
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 149
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 145
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 143
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients 142
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 141
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 139
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 137
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 137
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 134
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 134
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 134
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 133
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. 130
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 129
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. 123
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 122
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 120
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. 119
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 118
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms. 117
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project 109
Calreticulin: a new horizon for the testing and treatment of myeloproliferative neoplasms. 108
Validation of the Mayo alliance prognostic system for mastocytosis 107
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features 107
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice? 104
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC project 95
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia 92
Prognotic Impact of Mutations in Systemic Mastocytosis 92
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera 90
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 86
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease 84
BRAFV600E mutation in the wrong place: a case of concomitant polycythemia vera, hairy cell leukemia, and thyroid adenoma 77
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 75
Prognostic relevance of mutations in myelofi-brosis 75
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis 73
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis 73
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms 72
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 65
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement 65
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 64
CALR mutation burden in essential thrombocythemia and disease outcome 63
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 56
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 48
null 47
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 45
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients 43
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting 4
Totale 6.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 0 0 0 0 0 135 150 149 123 84 99 24
2020/2021619 42 64 13 120 29 49 31 40 67 76 54 34
2021/2022379 9 8 48 17 20 21 13 40 20 14 74 95
2022/20231.160 87 228 72 79 71 173 140 89 103 13 26 79
2023/2024481 25 40 64 18 51 60 12 102 11 32 34 32
2024/20252.335 84 283 196 502 845 425 0 0 0 0 0 0
Totale 6.816